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Abstract
Eosinophilic angiocentric fibrosis is a rare,benign cause of submucosal thickening and fibrosis within the
upper respiratory tract. It predominantly affects the nose although cases have been reported in the
subglottis. We describe four cases of the disease centred around the nasal cavity, with widespread
infiltration of the facial soft tissues and orbit in three of the four patients. Each underwent long term
follow up. Multiple surgical resections were required with two of our patients and, to date, medical
therapy has been of limited help.The disease process,with its clinical and characteristic histopathological
findings, is described.We also discuss the management of the disease following a comprehensive review
of, and comparison with, the few prior reported cases.
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Case studies
Case one
A 37-year-old woman presented as a tertiary referral
to our department in July 1995. She had originally
been seen and treated in Germany for some 18 years
prior to relocating to the United Kingdom. Her first
presentation was at age 19 when she had developed
a small skin lesion in the left frontonasal region
which appeared to extend into the nasal cavity. This
was subsequently biopsied, initially endonasally, and
a chronic inflammatory infiltrate was identified,
but no specific histological diagnosis could be
ascertained. The lesion thereafter grew dramatically
and a further external biopsy was performed some
months later. Histological diagnosis at this time
pointed towards an early form of scleroma and no
specific malignant features could be identified. A
lateral rhinotomy was performed at this stage with
removal of the mass, inferior turbinate and a large
amount of mucosa. Definitive histology once again
was nonspecific although frozen sections had
pointed to the possibility of mesenchymal
malignancy. Further biopsies and a subsequent
repeat lateral rhinotomy for formation of an
endonasal chocolate cyst confirmed nonspecific
perivascular round-cell inflammation.
Upon presentation to our care the patient had
been resident in the UK for a year. She had
developed thickening in the region of the frontal
process and infraorbital margin of the left maxillary
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Introduction
Eosinophilic angiocentric fibrosis (EAF) remains an
unusual, benign condition of the upper respiratory
tract.Since the first description in 1985,
1 some further
cases have been published.
2–8 The aetiology of the
condition remains unknown, but clinically there is
typically submucosal thickening with subsequent
fibrosis largely within the nasal cavity, although two
cases have been reported within the subglottis. The
nasal septum appears to be most commonly affected
although extension to the lateral wall has been seen.
The condition is slow-growing and until recently has
proved a diagnostic difficulty, with prior histological
reports giving no specific cause for the inflammation
and fibrosis evident.The specific histological features
include a perivascular inflammatory cell infiltration
with progressive fibrosis around small vessels,leading
to a characteristic whorling, ‘onion-skin’-type
pattern.
1  Eosinophils represent the predominant
inflammatory cells, particularly with progression of
the fibrosis. The histological appearance closely
resembles that of the equally rare skin lesion
granuloma faciale and is likely to represent a mucosal
variant thereof.
We report a further four cases of EAF centred
around the nasal cavity and describe their
management and long term follow up.We review the
limited pertinent literature currently available for
this rare condition and make comparisons between
our own and previously published cases.bone together with a deeply tethered, poorly healed
lateral rhinotomy scar. Her main complaints were of
crusting, perimenstrual epistaxis, epiphora and
symptoms of eustachian tube dysfunction . She was
penicillin-sensitive but otherwise denied any
allergies. Routine haematological screening,
including erythrocyte sedimentation rate (ESR) and
Anti-neutrophil cytoplasmic antibody (ANCA) assays,
was unremarkable.
The lateral rhinotomy was reopened and a
subdermal fibrous mass dissected out which
appeared to be contiguous with the orbital
periosteum which was resected. Inspection of the
maxillary sinus showed some polypoidal mucosal
changes although the ethmoid cavity was clear.A left
grommet was also inserted for a serous effusion.
Histological analysis confirmed features consistent
with granuloma faciale and its intranasal variant,
eosinophilic angiocentric fibrosis.
The patient remained well thereafter, with no
evidence of recurrence of the mass on follow up,
until some three years later when she presented with
a further nodular, discoloured area over the left
nasal bridge. An axial computed tomography (CT)
scan confirmed a soft tissue mass encroaching on the
orbit in the region of the medial canthus. To avoid
further surgical resection, with its concomitant
reconstruction difficulties, the patient was referred
to a specialist dermatologist who commenced her on
oral steroids and azathioprine. Her lesion improved
considerably with this treatment although she had to
discontinue it due to intolerance of side effects.
Over the next three years there was gradual
progression of the lesion and the patient was
re-referred,three months prior to the time of writing,
with obvious bilateral infiltration of the nasal bridge
extending into the glabella region, with a violaceous
lesion of the nasal skin. Computed tomography and
magnetic resonance imaging (MRI) scans confirmed
that the lesion extended into the soft tissues of the
contralateral medial canthal region and affected the
left anterior orbit. A radical clearance of the area
was undertaken through an extended lateral
rhinotomy with sacrifice of the affected overlying
skin, underlying cartilage and resection of the
intraorbital mass. The defect was repaired with a
median glabella flap together with skin grafting to
the exposed orbital fat.
Case two
A 68-year-old gentleman presented as a tertiary
referral to our care with a longstanding deformity in
the nasal bridge and forehead region. It appeared to
have gradually increased in size over some five years.
He had a degree of nasal blockage but was otherwise
well, with no other rhinological symptoms and no
history of allergies. On examination, other than the
swelling, there was hypertelorism, although
ophthalmological assessment was otherwise normal.
Intranasally, the disease process extended into the
nasal septum,which was thickened and widened thus
causing the obstruction. Radiologically, there
appeared to be a large mass in the glabella region
extending over the bridge of the nose and up to and
including the upper lateral cartilages. The mass
extended into both orbits, involving the orbital
periosteum (Figure 1). Haematological testing once
again showed no abnormality.Prior to referral,initial
biopsies had revealed no specific diagnosis,but areas
of chronic inflammatory infiltration were clearly
seen within the otherwise benign process.The lesion
was then further explored under our care through an
extended lateral rhinotomy incision. The mass was
extensively resected over the frontal and nasal
bones, including a cuff of orbital periosteum, until it
was felt a complete clearance had been achieved.
The structural aspect of the nasal septum was left
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FIG.1
(a) Axial CT showing mass in glabella region extending into orbital periosteum bilaterally. (b) Axial MRI (T1-weighted with
gadolinium) of the mass in glabella region extending into orbital periosteum bilaterally.
(a) (b)largely intact for support, although a portion of
submucoperiosteal fibrosis was resected for
diagnostic purposes. Histological evaluation of this
large mass of tissue confirmed the characteristic
findings associated with eosinophilic angiocentric
fibrosis. Post-operatively, and over long term follow
up of some six years, the patient remained well with
no evidence of return of the mass and minimal nasal
symptoms, although the nasal septum was noted to
remain rather wide.
Case three
A 57-year-old Indian lady was originally referred to
our department some 20 years ago with a nasal mass
affecting both the internal and external structure of
the nose, with extension into the maxillary cavity.
The left nasal cavity was noted to be narrowed by an
infiltrating mass which had also caused bony
enlargement around the maxilla.The patient had had
a prior lateral rhinotomy and went on to have a
further such procedure to remove recurrent disease.
At the time, a tuberculous mass, rhinoscleroma and
fungal infection were thought to be the likely
differential diagnoses, but each was excluded
histologically.Fibrosis with infiltration of eosinophils
was noted. Further biopsies confirmed a similar
picture, with no granulomatous disease present, and
serial cANCA and angiotensin-converting enzyme
(ACE) levels were normal. It was only on a
subsequent further lateral rhinotomy some years
later that the diagnosis of eosinophilic angiocentric
fibrosis was confirmed. The disease at the time had
progressed significantly to occupy the anterior
cheek, extending onto the nasal bridge, glabella
region and into the orbit as well as causing swelling
of the nasal septum and vestibular stenosis. Bone
was noted to be dehiscent in the anterior aspect of
the maxilla. Whilst the mass surrounding the orbit
was extensively removed, the tissue extending into
the orbit was left untouched at the patient’s request,
due to the obvious risks to vision. In an attempt to
prevent progression of disease, particularly into the
orbital tissues, the patient was referred for a
specialist dermatological opinion regarding medical
treatment.Over some years,treatment with dapsone,
hydroxychloroquine and azathioprine was variously
tried but proved to be less than successful, with no
obvious shrinkage of the mass and no inhibition of
recurrence. Oral steroids were briefly given and
produced some reduction in the mass,but the patient
was reluctant to continue with these in the longer
term. Pulsed high-dose parenteral steroid treatment
was also suggested, but again the patient would not
undergo such treatment.
At the time of writing the disease had progressed
significantly, with widespread infiltration of the left
orbit and midfacial tissues and extension across the
midline into the right medial canthus region (Figure
2). There was significant proptosis of the left eye,
with reduction in vision.The patient refused further
surgical intervention despite numerous attempts to
warn her of the progressive nature of the disease.
Case four
Our fourth case represents a less extensive variant of
the condition. A 58-year-old lady initially presented
with a one-year history of a firm mass occupying the
left lateral wall of the nose.The mass was removed via
a lateral rhinotomy and was found to extend from the
nasal bone down to the vestibule, involving the floor
of the nose but not the turbinates.The patient had an
uneventful recovery and at the time of writing, some
three years on, there was no recurrence of the mass.
Histopathological analysis once again was not specific
at the referring hospital but the definitive diagnosis
was made after referral to our department;the typical
features of a fibrous lesion with a whorled, nodular
architecture and scattered eosinophils were noted.
Histopathological findings
In their description of the histological findings,
Roberts and McCann
1 reported consistent features in
the biopsy specimens of their three patients.An early
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FIG.2
(a) Coronal CT showing massive infiltration of left orbit with lesion crossing midline to contralateral medial canthal region. (b)
Axial CT showing soft tissue mass extending bilaterally from glabella region with wide infiltration of left orbit.
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eosinophil-rich vasculitic picture emerged centred
around smaller blood vessels. No thrombosis or
fibrinoid necrosis was found but the small vessel
endothelium appeared swollen and leucocytoclasis
featured. Whilst a granulomatous-type picture was
present, the absence of multinucleated giant cells or
epithelioid histiocytes excluded true granulomas.
Further reports
3–8 confirmed this picture of a
perivascular inflammatory response involving
capillaries and venules but not other vessels. Whilst
eosinophils predominate, lymphocytes and plasma
cells are also present. Accompanying this picture, in
adjacent areas mural thickening in an ‘onion skin’
pattern appears. This intimal fibrosis, with
characteristic whorling of the collagen fibres and
reticulin, is thought to represent a later stage of the
disease process. Eosinophils begin to predominate
further as the other inflammatory cells progressively
reduce in number. The histological findings in our
cases are consistent with this picture (Figures 3 to 5),
and whilst in case one we were unable to obtain the
original histopathological slides from the patient’s
initial biopsies in Germany, we did receive pathology
reports which were in keeping with the diagnosis,
together with confirmation from subsequent histology.
Discussion
The absence of any clear aetiology for this rare
condition certainly warrants reporting of cases to
enable further study into the disease process. It
appears clear that, to date, cases may have gone
undiagnosed,and pathological reports of nonspecific
chronic inflammation/fibrosis of nasal biopsies may
require further evaluation, particularly in the
presence of what appears to be a progressive
inflammatory process. Eosinophilic angiocentric
fibrosis is a clear descriptive term applied to the
biopsies of three patients by Roberts and McCann,
1,2
although an earlier description of an intranasal mass
arising in a 49-year-old man with typical features of
granuloma faciale appears to be the first report of
this condition.
9 Fourteen further cases have been
reported in the literature, the majority within the
nasal cavity although the subglottis has also been
involved in two cases.
1,3 Both of these patients
required laryngotracheoplasty following breathing
difficulties. Histologically, EAF resembles
granuloma faciale closely, with both conditions
having a vasculitic appearance with prominent
eosinophilic infiltration. The latter stages show an
angiocentric fibrotic pattern although it is not so
marked in granolma faciale.The relationship of EAF
to granuloma faciale is still under some debate
although, in the presence of such histological
similarity and the coexistence of both lesions in
many of the reported cases, it seems likely that EAF
is a submucosal variant affecting the upper
respiratory tract.
Table 1 gives a summary of the reported EAF cases
presenting within the nasal cavity to date. Clearly,
there appears at this stage to be a female
preponderance, which is somewhat unusual
considering granuloma faciale is more common in
men. If EAF indeed represents a variant of
granuloma faciale, it is not entirely clear why this
inherent difference is seen.The nasal septum appears
to be involved in most cases, and when considering
causes for a septal thickening EAF should be
entertained as an uncommon,but definite,differential
diagnosis. The lateral wall of the nose may also be
FIG.3
Venule shows concentric infiltration by polymorphic
inflammatory cell infiltrate, rich in eosinophils (H & E;  10).
FIG.4
Polymorphic perivascular inflammatory cell infiltrate,including
lymphocytes, plasma cells and eosinophils (H & E;  20).
FIG.5
Concentric fibrosis around central vessel (H & E;  10).affected and this may clinically be used to exclude the
midline granulomatous disease differentials.
Wegener’s granulomatosis was excluded by cANCA
assays in all cases except that reported by Loane et al.
4
These authors reported a possible coexistence of
EAF in a patient with known Wegener’s
granulomatosis that had been treated successfully
with immunosupression therapy. The report
speculated that EAF may represent an exaggerated
fibrosis of the upper airway rather than a distinct
clinical entity. Our patients’ histologies did not show
these appearances, but were rather more in keeping
with the original description of this condition,with no
evidence of granulomatous disease, and this indeed
appears to be the case in all the other cases thus far
reported. As would be expected by the submucosal
nature of the disease process,ulceration has not been
a feature in any of the cases.
An allergic basis to the condition was suggested in
early reports, based on specific allergies suffered by
the reported patients and the abundant eosinophilic
presence. There appears to be little definite
correlation, however, with allergic history in
subsequent published cases and it would seem
unlikely that this represents an aetiological factor for
the disease. In our series one of the patients had a
penicillin sensitivity,with no other allergies reported.
Reviewing the prior literature, little comment has
been made regarding the radiological findings and
indeed it appears many of the cases were not imaged
as the presenting feature was related to the nasal
septum alone. Of those cases reported that mention
radiology, it appears that plain sinus X-rays showed
no abnormality
1 and CT findings showed nonspecific
soft-tissue swelling of the septum and lateral walls
with no true bony destruction.
6 In our series bony
destruction was clearly a feature, with the disease
process affecting the orbital periosteum. Depending
on the extent of disease, both CT and MRI imaging
is likely to be of benefit in assessment.
Three of our cases would appear to be rather
extensive examples of the disease, which extended
from the intranasal cavity into the paranasal sinus
and infiltrated the orbital contents.In all of our cases
the disease process was slow-growing, and in two of
our cases disease was recurrent despite several
radical attempts at surgical clearance. The length of
time for disease progression reflects the slow,
indolent nature of the disease process, and the rarity
of the condition and the scarcity of previously
published literature also result in delay in diagnosis.
With growing awareness of the condition, earlier
histological diagnosis may assist in appropriate
management strategies and even more radical
surgery  ab initio; the two cases in which this was
undertaken in the first instance had no recurrence at
the time of writing.
Surgical resection appears to be the treatment
option of choice although recurrences are common
in most prior published cases and multiple excisions
are frequently required. Steroid therapy has had
limited reported success, although we did find that
two of our patients responded somewhat to this and
to cytotoxic treatment, but unfortunately could not
tolerate the side effects.The use of dapsone has been
reported in granuloma faciale
13,14 but unfortunately
did not prove to be successful in the one patient for
whom it was prescribed in our series.
Hydroxychloroquine, seen to be of occasional
benefit in vasculitic disorders, was also tried but was
not helpful. The use of pulsed methylprednisolone
was suggested as a possible treatment for our third
patient, based on experiences of this approach for
thyrotoxic-induced severe exophthalmos.
15 This
therapy was refused by our patient due to anxiety
about steroid toxicity; however, it remains a possible
treatment option for patients with progressive
disease unsuitable for, or unwilling to undergo,
surgery.
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TABLE I
REPORTED CASES OF EOSINOPHILIC ANGIOCENTRIC FIBROSIS WITHIN THE NASAL CAVITY
Report Age/sex Presenting lesion Management Long term follow up
Holmes & Panje
9 49 Female Intranasal mass Surgical excision Unknown
Roberts & McCann
1 27 Female Septal/turbinate thickening Surgical excisions Residual disease
59 Female Septal thickening/mass Surgical excisions Residual disease
over nasal bridge
54 Female Septal thickening Surgical excisions/ Unavailable
radiotherapy
50 Female Submucosal mass over  Surgical excisions Residual disease
alar cartilage
Altemani et al.
5 54 Female Septal/lateral wall thickening Surgical excisions Residual disease
Matai et al.
7 51 Male Septal thickening Surgical excision Residual disease
Thompson & Heffner
8 28 Male Septal/maxillary sinus mass Surgical excision/ Residual disease
steroids
49 Female Septal thickening Surgical excision/ Residual disease
steroids
64 Female Septal/maxillary sinus mass Surgical excision/ Residual disease
steroids
Burns et al.
6 38 Male Septal thickening/mass Surgical excisions Residual disease
from alar cartilage
Loane et al.
4 42 Male Septal deviation/nasal Surgical excision Unavailable
adhesions post-septoplasty
Pereira et al.
10 52 Male Septum Surgical excisions Unavailable
Tabaee et al.
11 79 Male Septum and lateral wall Surgical resection Unavailable
Nguyen et al.
12 45 Male Septum/middle meatus Surgical excision UnknownConclusion
Our long term follow up of these four patients
appears to show the slow-growing but in some cases
progressive nature of eosinophilic angiocentric
fibrosis. The nature of this disease remains
unknown, but as more cases are reported in the
literature the natural history of this condition is
becoming clearer. The nasal septum is most
commonly affected although the lateral wall may
also be involved. Soft tissue swelling around the
midface may also be a presenting feature and
subsequent infiltration into the orbital structures
appears to be inevitable if the disease progresses,
despite surgical clearances. Surgical resection of the
disease remains the main treatment although
multiple procedures are often required. Short term
steroid treatment proved to be of some benefit in
two of our more difficult patients, but long term use
and, indeed, pulsed high-dose treatment require
further evaluation. The characteristic histological
findings of EAF are now well established and, with
increasing awareness amongst histopathological
colleagues, further reports of this rare condition
should be produced.
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